Renaissance Technologies - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$82,778
+12.6%
682,878
+6.4%
0.14%
+33.0%
Q2 2023$73,531
-33.8%
642,078
-20.4%
0.11%
-28.4%
Q1 2023$111,157
+19.3%
806,478
+12.2%
0.15%
+16.5%
Q4 2022$93,152
-99.9%
718,878
-18.7%
0.13%
-8.0%
Q3 2022$97,737,000
+231.5%
884,178
+124.8%
0.14%
+294.3%
Q2 2022$29,480,000
+153.6%
393,278
+164.3%
0.04%
+150.0%
Q1 2022$11,624,000
-45.2%
148,800
-36.8%
0.01%
-46.2%
Q4 2021$21,214,000
+2599.0%
235,578
+2671.5%
0.03%
+2500.0%
Q3 2021$786,000
-92.1%
8,500
-93.4%
0.00%
-91.7%
Q2 2021$9,949,000
-54.8%
127,978
-18.3%
0.01%
-45.5%
Q3 2020$21,988,000
-70.0%
156,578
-65.7%
0.02%
-65.1%
Q2 2020$73,192,000
+839.1%
456,478
+472.9%
0.06%
+687.5%
Q1 2020$7,794,000
-70.3%
79,678
-77.1%
0.01%
-63.6%
Q3 2019$26,217,000
+85.8%
348,078
+274.8%
0.02%
+83.3%
Q2 2019$14,113,000
-19.1%
92,878
-14.0%
0.01%
-33.3%
Q3 2018$17,440,000
-79.3%
107,978
-85.6%
0.02%
-60.9%
Q2 2018$84,443,000
+345.6%
751,256
+193.7%
0.05%
+119.0%
Q1 2018$18,951,000
+643.8%
255,778
+197.1%
0.02%
+425.0%
Q1 2017$2,548,000
+89.3%
86,078
+75.4%
0.00%
+100.0%
Q4 2016$1,346,000
-81.5%
49,078
-74.0%
0.00%
-87.5%
Q4 2015$7,275,000
-55.4%
188,578
-62.9%
0.02%
-59.0%
Q3 2015$16,303,000
+81.5%
507,738
+72.0%
0.04%
+95.0%
Q2 2015$8,982,000
+70.6%
295,178
-25.6%
0.02%
+81.8%
Q1 2015$5,266,000
+121.5%
396,539
+141.4%
0.01%
+83.3%
Q4 2014$2,377,000164,2780.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders